iShares Health Innovation Active ETF BMED

Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis BMED

Will BMED outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Health Innovation Active ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 42.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

5.19 716,746
Healthcare

Danaher Corp

5.19 716,050
Healthcare

Gilead Sciences Inc

5.00 689,654
Healthcare

AbbVie Inc

4.61 635,925
Healthcare

Thermo Fisher Scientific Inc

4.41 608,895
Healthcare

Johnson & Johnson

4.17 575,015
Healthcare

IQVIA Holdings Inc

3.75 516,999
Healthcare

Waters Corp

3.66 505,298
Healthcare

Biogen Inc

3.52 485,642
Healthcare

Vertex Pharmaceuticals Inc

3.35 462,164
Healthcare

Sponsor Center